Literature DB >> 12162874

Herpes simplex virus type 1 infection induces upregulation of interleukin-23 (p19) mRNA expression in trigeminal ganglia of BALB/c mice.

Eeva K Broberg1, Niko Setälä, Juha-Pekka Erälinna, Aimo A Salmi, Matias Röyttä, Veijo Hukkanen.   

Abstract

We investigated the expression kinetics of several cytokines in trigeminal ganglia (TG) and in brains of BALB/c mice during the course of ocular herpes simplex virus type 1 (HSV-1) infection. All mice recovered from the infection within 2 weeks. The quantitative rapid real-time RT-PCR method was used to analyze interleukin-4 (IL-4), interferon-gamma (IFN-gamma), IL-12p35, IL-12p40, and the recently described IL-23 (p19) mRNA in TG, brain, and splenocyte samples. In TG, we found elevated expression of mRNA for IL-23 (p19) from early acute infection (day 3) to the beginning of the latent phase (day 14). The increase was not detected in brain or in the spleen. IL-4 expression occurred in both TG and brain from the beginning of the experiment to the latent phase. During the latent phase (days 14 and 31), IL-4 expression was significantly elevated in the brain when compared with the uninfected controls (p < 0.05). Considerable expression of IFN-gamma mRNA was detected in TG of mice during acute HSV-1 infection. The expression of IL-23 was detected also in the brains of the mice, even though no significant changes were found during the acute HSV-1 infection. This is, to our knowledge, the first report to show elevated expression of IL-23 (p19) mRNA (p < 0.05) during viral infection in TG of mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12162874     DOI: 10.1089/10799900260100123

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  10 in total

1.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

Review 2.  IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS.

Authors:  Govardhana Rao Yannam; Tanuja Gutti; Larisa Y Poluektova
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-24       Impact factor: 4.147

3.  Immunomodulation by roquinimex decreases the expression of IL-23 (p19) mRNA in the brains of herpes simplex virus type 1 infected BALB/c mice.

Authors:  J Peltoniemi; E K Broberg; A Halenius; N Setala; J-P Eralinna; A A Salmi; M Roytta; V Hukkanen
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

4.  Murine gammaherpesvirus-68 elicits robust levels of interleukin-12 p40, but not interleukin-12 p70 production, by murine microglia and astrocytes.

Authors:  Amy Rasley; Kenneth L Bost; Ian Marriott
Journal:  J Neurovirol       Date:  2004-06       Impact factor: 2.643

5.  Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.

Authors:  Eeva K Broberg; Jutta Peltoniemi; Michaela Nygårdas; Tero Vahlberg; Matias Röyttä; Veijo Hukkanen
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 6.  Macrophages and cytokines in the early defence against herpes simplex virus.

Authors:  Svend Ellermann-Eriksen
Journal:  Virol J       Date:  2005-08-03       Impact factor: 4.099

7.  Jagged-1 signaling suppresses the IL-6 and TGF-β treatment-induced Th17 cell differentiation via the reduction of RORγt/IL-17A/IL-17F/IL-23a/IL-12rb1.

Authors:  Yuan Wang; Feiyue Xing; Siqi Ye; Jia Xiao; Jingfang Di; Shan Zeng; Jing Liu
Journal:  Sci Rep       Date:  2015-02-04       Impact factor: 4.379

8.  ssICAM-1, IL-21 and IL-23 in patients with tick borne encephalitis and neuroborreliosis.

Authors:  Anna Moniuszko; Sławomir Pancewicz; Piotr Czupryna; Sambor Grygorczuk; Renata Świerzbińska; Maciej Kondrusik; Paweł Penza; Joanna Zajkowska
Journal:  Cytokine       Date:  2012-06-15       Impact factor: 3.861

9.  VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model.

Authors:  Lin Chen; Shao-xia Lin; Sanober Amin; Lut Overbergh; Giacomo Maggiolino; Lawrence S Chan
Journal:  Immunol Cell Biol       Date:  2010-01-12       Impact factor: 5.126

10.  A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunity.

Authors:  Michaela Nygårdas; Henrik Paavilainen; Nadine Müther; Claus-Henning Nagel; Matias Röyttä; Beate Sodeik; Veijo Hukkanen
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.